Boothbay Fund Management, LLC Xenon Pharmaceuticals Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

A detailed history of Boothbay Fund Management, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 30,145 shares of XENE stock, worth $1.17 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
30,145
Previous 30,145 -0.0%
Holding current value
$1.17 Million
Previous $1.18 Million 0.94%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$36.25 - $43.75 $7,830 - $9,450
-216 Reduced 0.71%
30,145 $1.18 Million
Q1 2024

May 15, 2024
SELL
$42.66 - $50.04 $422,120 - $495,145
-9,895 Reduced 24.58%
30,361 $1.31 Million
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $1.16 Million - $1.87 Million
40,256 New
40,256 $1.85 Million
Q2 2023

Aug 14, 2023
SELL
$34.84 - $43.54 $64,175 - $80,200
-1,842 Reduced 15.58%
9,983 $384,000
Q3 2022

Nov 14, 2022
SELL
$30.79 - $39.82 $445,869 - $576,633
-14,481 Reduced 55.05%
11,825 $427,000
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $50,371 - $69,616
1,980 Added 8.14%
26,306 $800,000
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $149,285 - $197,123
5,950 Added 32.38%
24,326 $744,000
Q4 2021

Feb 14, 2022
SELL
$15.6 - $35.4 $513,988 - $1.17 Million
-32,948 Reduced 64.2%
18,376 $574,000
Q3 2021

Nov 15, 2021
SELL
$14.86 - $19.45 $660,274 - $864,221
-44,433 Reduced 46.4%
51,324 $784,000
Q2 2021

Aug 16, 2021
BUY
$16.81 - $20.0 $83,058 - $98,820
4,941 Added 5.44%
95,757 $1.78 Million
Q1 2021

May 17, 2021
BUY
$13.65 - $21.31 $659,335 - $1.03 Million
48,303 Added 113.62%
90,816 $1.63 Million
Q4 2020

Feb 12, 2021
BUY
$9.49 - $16.04 $56,892 - $96,159
5,995 Added 16.42%
42,513 $654,000
Q3 2020

Nov 16, 2020
SELL
$10.82 - $13.35 $88,366 - $109,029
-8,167 Reduced 18.28%
36,518 $404,000
Q2 2020

Aug 14, 2020
SELL
$10.21 - $14.9 $207,303 - $302,529
-20,304 Reduced 31.24%
44,685 $560,000
Q1 2020

May 15, 2020
BUY
$8.08 - $17.57 $112,974 - $245,663
13,982 Added 27.41%
64,989 $737,000
Q3 2019

Nov 14, 2019
SELL
$8.74 - $10.51 $6,686 - $8,040
-765 Reduced 1.48%
51,007 $460,000
Q2 2019

Aug 14, 2019
SELL
$8.51 - $10.75 $190,538 - $240,692
-22,390 Reduced 30.19%
51,772 $510,000
Q1 2019

May 15, 2019
BUY
$6.39 - $10.42 $252,277 - $411,381
39,480 Added 113.83%
74,162 $753,000
Q4 2018

Feb 14, 2019
BUY
$5.61 - $12.62 $86,433 - $194,436
15,407 Added 79.93%
34,682 $219,000
Q3 2018

Nov 14, 2018
SELL
$9.0 - $14.9 $144,396 - $239,055
-16,044 Reduced 45.43%
19,275 $254,000
Q2 2018

Aug 14, 2018
BUY
$4.8 - $9.2 $169,531 - $324,934
35,319 New
35,319 $325,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email